272Bio
272Bio is focused on veterinary medicine drug discovery and development by creating biotherapeutics for livestock and companion animal disorders. They use technologies to reduce production costs and provide therapies.
- Antibody development
- Cellular and assay technologies
- Biotherapeutics for animal health
- Protein expression and purification
- Chemistry manufacturing and controls
Locations
Digital Popularity
Social Media
LinkedIn609 Followers
Company Details
272Bio is operated by 272bio Limited and is a Active company incorporated on 21 June 2019 with the registered office located in . 272bio Limited was registered 6 years ago.
Status
Active
Size
Small
Directors
5
Age
6 years old
Employees
14
Turnover
Unreported
Total Assets
£4.88M
Cash in Bank
£2.3M
Total Liabilities
-£1.31M
Teams
11
6
2
1
3
Principal Scientist • Joined Jul 2024
Principal Scientist • Joined Jan 2024
Chief Financial Officer • Joined Jun 2023
Operations Director • Joined Mar 2020
Head Of Antibody Research • Joined Jul 2022
Research Technician • Joined Jun 2024
Associate Scientist • Joined Jun 2022
SME Automation & Innovation • Joined Apr 2022
Scientist • Joined Jun 2022
Scientist • Joined Jan 2021
Principal Scientist • Joined Jul 2024
Senior Scientist • Joined Aug 2021
Research Technician • Joined Jun 2024
Associate Scientist • Joined Jun 2022
Scientist • Joined Jun 2022
Scientist • Joined Jan 2021
Chief Financial Officer • Joined Jun 2023
Operations Director • Joined Mar 2020
Project Leader • Joined Aug 2021
Head Of Antibody Research • Joined Jul 2022
SME Automation & Innovation • Joined Apr 2022
Senior Scientist (Molecular Biology And Immunology) • Joined Aug 2021
View 11 members